Literature DB >> 12089712

Glomerular filtration rate assessment in individuals after orthotopic liver transplantation based on serum cystatin C levels.

Otto Schück1, Halima Gottfriedova, Jan Maly, Antonin Jabor, Milena Stollova, Iva Bruzkova, Jelena Skibova, Miroslav Ryska, Julius Spicak, Pavel Trunecka, Jana Novakova.   

Abstract

Individuals after orthotopic liver transplantation (OLT) often show renal dysfunction, which may substantially affect the post-OLT course. Renal function after OLT is commonly assessed by means of serum creatinine (S(cr)) concentration or renal creatinine clearance (C(cr)). A glomerular filtration rate (GFR) estimate based on S(cr) level is not accurate enough because even a more marked decrease in GFR need not be associated with an increase in S(cr) level, especially in jaundiced patients. The study intends to try to estimate GFR in individuals after OLT by means of determining serum cystatin C (S(cyst)) concentrations. In 58 individuals (mean age, 49 +/- 7 years; 31 men, 27 women) at various intervals from OLT (mean, 14 +/- 10 months), GFR was estimated by using simultaneous determinations of S(cyst), S(cr), C(cr), and renal inulin clearance (C(in)). In most subjects (91.3%), C(in) was decreased to less than the lower limit of normal (80 mL/min/1.73 m(2)). A significant correlation (r = 0.70; P <.001) was found between 1/S(cyst) and C(in). Receiver operating characteristic analysis was performed on S(cyst) and S(cr) using a C(in) cutoff value of 80 mL/min/1.73 m(2). The area under the curve for S(cyst) was 0.912 +/- 0.044, and that for S(cr), 0.899 +/- 0.049. There was no statistically significant difference between these values. The sensitivity for a S(cyst) level of 1.20 mg/L (upper limit of normal value) to detect a decrease in GFR (measured as C(in)) below the lower limit of normal (80 mL/min/1.73 m(2)) was 96.1%. The sensitivity of S(cyst) level was significantly greater (P <.01) than the sensitivity of S(cr) level for men and at borderline significance for women (P =.05). Findings support the assumption that a S(cyst) level less than 1.2 mg/L indicates with a high degree of probability (P <.001) that GFR is not decreased to less than the normal limit. S(cyst) assessment in individuals after OLT could be proposed as a confirmatory test of a decrease in GFR in individuals with normal S(cr) levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089712     DOI: 10.1053/jlts.2002.33957

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  8 in total

Review 1.  Commentary: clinical diagnostic use of cystatin C.

Authors:  Davis Massey
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients.

Authors:  Alina M Allen; W Ray Kim; Joseph J Larson; Colin Colby; Terry M Therneau; Andrew D Rule
Journal:  Transplantation       Date:  2015-07       Impact factor: 4.939

3.  Cystatin C--a paradigm of evidence based laboratory medicine.

Authors:  Janice S C Chew; Mohammed Saleem; Christopher M Florkowski; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

4.  Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance.

Authors:  Rossini Botev; Jean-Pierre Mallié; Cecilé Couchoud; Otto Schück; Jean-Pierre Fauvel; Jack F M Wetzels; Nelson Lee; Natale G De Santo; Massimo Cirillo
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

5.  Serum cystatin C levels in children with sickle cell disease.

Authors:  Ofelia Alvarez; Gaston Zilleruelo; Dale Wright; Brenda Montane; Gabriela Lopez-Mitnik
Journal:  Pediatr Nephrol       Date:  2006-02-21       Impact factor: 3.714

Review 6.  Principles and clinical application of assessing alterations in renal elimination pathways.

Authors:  Susan E Tett; Carl M J Kirkpatrick; Annette S Gross; Andrew J McLachlan
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 7.  Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Authors:  Mitra K Nadim; John A Kellum; Andrew Davenport; Florence Wong; Connie Davis; Neesh Pannu; Ashita Tolwani; Rinaldo Bellomo; Yuri S Genyk
Journal:  Crit Care       Date:  2012-02-09       Impact factor: 9.097

8.  Impact of sustained virologic response on chronic kidney disease progression in hepatitis C.

Authors:  Elizabeth S Aby; Tien S Dong; Jenna Kawamoto; Joseph R Pisegna; Jihane N Benhammou
Journal:  World J Hepatol       Date:  2017-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.